Phosphatidylinositol 3-kinase Signaling as a Therapeutic Target for Cervical Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|13|2|143-156

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.13, Iss.2, 2013-02, pp. : 143-156

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cells

By  

Current Medicinal Chemistry, Vol. 18, Iss. 18, 2011-06 ,pp. : 2715-2726

Bentham Science Publishers

Access to resources Recommend Favorite

Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer?

By Fujino H.   Regan J.W.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 7, 2003-07 ,pp. : 335-340

Elsevier

Access to resources Recommend Favorite

New phosphatidylinositol 3-kinase inhibitors for cancer

By Bowles Daniel W   Jimeno Antonio  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 4, 2011-04 ,pp. : 507-518

Informa Healthcare

Access to resources Recommend Favorite

Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia

By Evangelisti Camilla  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 8, 2013-08 ,pp. : 921-936

Informa Healthcare

Access to resources Recommend Favorite

The Phosphoinositide 3-Kinase Signaling Pathway as a Therapeutic Target in Grade IV Brain Tumors

By  

Current Cancer Drug Targets, Vol. 11, Iss. 8, 2011-10 ,pp. : 894-918

Bentham Science Publishers

Access to resources Recommend Favorite